Streetbeat News

Products Services

UNH

UnitedHealth Group (UNH) is actively addressing the aftermath of a significant cyberattack on the U.S. health system and Change Healthcare services. The company is releasing medical claims preparation software as part of service resumption efforts, having already restored Change Healthcare's electronic payments platform and 99% of pharmacy network services. UnitedHealth has provided over $2 billion in financial assistance to affected providers and has implemented measures to ease access to funding and reduce administrative burdens.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:49 pm

ZVSA

ZyVersa Therapeutics' shares surged following the announcement of IRB approval for a Phase 2a clinical trial of VAR 200 in diabetic kidney disease patients. This marks a significant step in the development of treatments for diabetic kidney disease, potentially opening new avenues for the company's growth and product pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:48 pm

SNOW

Recent options activity for Snowflake (NYSE:SNOW) shows a mix of bullish and bearish sentiment among investors, with a notable volume of trades focusing on a price window from $130.0 to $240.0. The company, known for its data lake, warehousing, and sharing solutions, has seen its stock price increase by 0.54% to $157.82. Analysts have set an average price target of $224.0, with specific targets ranging from $170 to $265. The next earnings report is expected in 65 days, and current RSI values suggest the stock may be oversold.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 2:46 pm

AAPL

GOOGL

Wedbush's Dan Ives suggests a potential partnership between Apple Inc. (AAPL) and Alphabet Inc. (GOOGL/GOOG) could significantly boost Apple's AI capabilities by integrating Google's Gemini AI models into iPhone software. This collaboration could make Apple a leader in personalized AI and result in substantial payments from Apple to Google, leveraging their existing search partnership and potentially impacting 1.4 billion devices.

Portfolio Pulse from Rounak Jain

March 18, 2024 | 2:43 pm

WW

Oprah Winfrey is hosting 'An Oprah Special: Shame, Blame and the Weight Loss Revolution' to discuss the impact of prescription weight loss medications. The special, airing on ABC, will feature a live audience and medical experts. Winfrey, who recently left Weight Watchers' board and donated her shares, aims to address health care, economy, lifestyle, and cultural impacts without conflict of interest. She uses weight loss medication herself and wants to empower viewers with information.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:40 pm

SCHW

Charles Schwab Corporation (NYSE:SCHW) has published a blog post explaining the impact of the SEC's rule change to shorten the settlement period for most U.S. securities to T+1, effective May 28. The post highlights the benefits and considerations for investors, including potential tax implications and the ability to buy stocks closer to dividend dates.

Portfolio Pulse from Aaron Bry

March 18, 2024 | 2:38 pm

TSLA

Tesla Inc (NASDAQ:TSLA) shares are up after announcing Model Y price increases in several countries and the U.S. Despite this, Goldman Sachs analyst Mark Delaney maintained a Neutral rating on Tesla, lowering the price target from $220 to $190 due to production challenges and weakening EV demand. Tesla's recent performance has been affected by declining demand in the EV market, pricing wars, disappointing delivery numbers, and a significant sales drop in China.

Portfolio Pulse from Adam Eckert

March 18, 2024 | 2:38 pm

DASH

SBH

DoorDash Inc (NASDAQ:DASH) has announced new partnerships with Sally Beauty Holdings Inc (NYSE:SBH) and M·A·C Cosmetics, alongside an expanded offering with Sephora, to deliver beauty, hair, makeup, and nail essentials on-demand in under an hour. This expansion builds on DoorDash's beauty on-demand service launched in 2021, now featuring over 400,000 products. The service is available from over 2,000 Sally Beauty stores and all M·A·C stores across the U.S., with Sephora's Beauty Insider members gaining access to exclusive sale events.

Portfolio Pulse from Shivani Kumaresan

March 18, 2024 | 2:37 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) announced positive results from the DUO-E Phase 3 trial of Imfinzi plus Lynparza in pMMR advanced or recurrent endometrial cancer, showing significant clinical benefits over chemotherapy alone. The combination therapy demonstrated improvements in key secondary efficacy endpoints, including duration of response and reduction in the risk of second progression or death. Additionally, AstraZeneca revealed a new pricing policy for its U.S. inhaled respiratory medicines, capping the cost at $35 per month for eligible patients starting June 1, 2024. AZN shares slightly declined by 0.24% to $66.15.

Portfolio Pulse from Vandana Singh

March 18, 2024 | 2:25 pm

USO

XOM

During a live interview on CNBC, Exxon Mobil's CEO Darren Woods stated that the demand for oil and petroleum products remains very healthy. This indicates a positive outlook for the oil industry, potentially impacting related stocks and ETFs.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:22 pm